Trial Profile
An evaluation of the efficacy and safety of tegaserod 6 mg bid given orally to Chinese patients with chronic constipation
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 24 Apr 2013
Price :
$35
*
At a glance
- Drugs Tegaserod (Primary)
- Indications Constipation
- Focus Therapeutic Use
- 15 Feb 2007 Results have been reported.
- 15 Feb 2007 Status changed from recruiting to completed.
- 19 Nov 2005 New trial record.